InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-51.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Keutzer Timothy, Directeur du Développement. Director active across 1 company, notably Spero Therapeutics, Inc.. Aggregated, 9 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €5k. Activity tracked since 26 August 2021. The latest transaction was disclosed on 3 February 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations9 total
266,139 shares0Common StockSEC:0000950170-25-014866:0
2,213 shares@ US$1.3555.3% of flowCommon StockSEC:0000950170-24-101998:0
239,731 shares0Common StockSEC:0000950170-24-011501:0
1,854 shares@ US$1.2644.7% of flowCommon StockSEC:0000950170-23-045450:0
265,957 shares0Common StockSEC:0000899243-23-003948:0
38,014 shares0Common StockSEC:0000899243-22-004589:0
38,014 shares0Common StockSEC:0000899243-22-004589
24,067 shares0Common StockSEC:0000899243-21-034499
24,067 shares0Common StockSEC:0000899243-21-034499:0
9 of 9 declarations
About Keutzer Timothy
Keutzer Timothy is the Chief Development Officer at Spero Therapeutics, Inc. He is responsible for managing development initiatives and the company's growth strategy. His role is essential to ensure that Spero achieves its objectives in developing new treatments.
